Cited by 104Craniofacial Disorders and TreatmentsBone Metabolism and Diseasesdental development and anomalies

Early onset of craniosynostosis in an Apert mouse model reveals critical features of this pathology

Open access
Holmes, Greg, Rothschild, Gerson, Roy, Upal Basu, Deng, Chu-Xia, Mansukhani, Alka, Basilico, Claudio·2009·Developmental Biology

Abstract

Activating mutations of FGFRs1-3 cause craniosynostosis (CS), the premature fusion of cranial bones, in man and mouse. The mechanisms by which such mutations lead to CS have been variously ascribed to increased osteoblast proliferation, differentiation, and apoptosis, but it is not always clear how these disturbances relate to the process of suture fusion. We have reassessed coronal suture fusion in an Apert Fgfr2 (S252W) mouse model. We find that the critical event of CS is the early loss of basal sutural mesenchyme as the osteogenic fronts, expressing activated Fgfr2, unite to form a contiguous skeletogenic membrane. A mild increase in osteoprogenitor proliferation precedes but does not accompany this event, and apoptosis is insignificant. On the other hand, the more apical coronal suture initially forms appropriately but then undergoes fusion, albeit at a slower rate, accompanied by a significant decrease in osteoprogenitor proliferation, and increased osteoblast maturation. Apoptosis now accompanies fusion, but is restricted to bone fronts in contact with one another. We correlated these in vivo observations with the intrinsic effects of the activated Fgfr2 S252W mutation in primary osteoblasts in culture, which show an increased capacity for both proliferation and differentiation. Our studies suggest that the major determinant of Fgfr2-induced craniosynostosis is the failure to respond to signals that would halt the recruitment or the advancement of osteoprogenitor cells at the sites where sutures should normally form.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ydbio.2009.01.026

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The cellular consequences of FGFR2/FGFR3 mutation include enhanced proliferation, differentiation, and apoptosis of osteoblasts bordering the cranial suture mesenchyme; premature differentiation is probably the most important factor leading to craniosynostosis.

    “The cellular consequences of mutation are complex, including enhancement of proliferation, differentiation and apoptosis of osteoblasts bordering the cranial suture mesenchyme; premature differentiation is probably the most important factor leading to craniosynostosis.11,12”

    From Craniosynostosis (2011) · cites this paper as [12]

    Split into 2 atoms — 0 confirmed, 1 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Mutations in FGFR2 and FGFR3 tend to be highly localised, recurrent missense substitutions that encode gain-of-function proteins.

    “Mutations in FGFR2 and FGFR3 tend to encode highly localised, recurrent missense substitutions encoding proteins with gain-of-function properties.”

    From Craniosynostosis (2011) · cites this paper as [12]

    The Introduction (page unavailable) describes activating mutations in FGFR1–3, supporting the gain-of-function aspect for FGFR2 and FGFR3. The Results section on Fgfr expression (page unavailable) also describes the activating effect of the FGFR2 S252W substitution. Neither passage establishes that mutations in both genes tend to be highly localised, recurrent missense substitutions. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Lomri A Lemonnier J Hott M de Parseval N Lajeunie E Munnich A Renier D Marie PJ 1998 Increased calvaria cell differentiation and bone matrix formation induced by fibroblast growth factor receptor 2 mutations in Apert syndrome J Clin Invest 101 1310 7 9502772 PMC508685

Cited by

Sorted by citations

Authors
Holmes, G., Rothschild, G., Roy, U. B., Deng, C.-X., Mansukhani, A., & Basilico, C.
Affiliations
  • NYU Langone Health (US)
  • National Institutes of Health (US)
Corresponding author
Basilico, Claudio
Venue
Developmental Biology
Publisher
Elsevier BV
Published
2009-04
Volume
328
Issue
2
Pages
273-284
ISSN
0012-1606 (ISSN-L)
OpenAlex
W2046072419
Cited by
104
References
55
Citations by year
2026: 3 · 2025: 1 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 8 · 2020: 5 · 2019: 3 · 2018: 7 · 2017: 3 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 9 · 2012: 13
FWCI
6.24
Type
journal article
Language
en
Open access
Locations
  • Developmental Biology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR 051358, R01AR051358)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Craniofacial Disorders and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › dental development and anomalies
Keywords
craniosynostosis, Apert syndrome, FGFR signaling, osteogenic differentiation, osteoblast apoptosis, osteoblasts, mouse model
MeSH terms
Acrocephalosyndactylia, Animals, Cell Differentiation, Cells, Cultured, Craniosynostoses, Mesoderm, Mice, Mutant Strains, Osteoblasts, Stem Cells, Apoptosis, Cell Proliferation, Mice, Receptor, Fibroblast Growth Factor, Type 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review